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Summary We have previously reported that γ-tocopherol (γ-Toc) displays a natriuretic
potency in rats fed a NaCl diet and administered 20 mg γ-Toc. In this study, we investigated
whether γ-Toc has natriuretic potency at a dose lower or higher than 20 mg in rats given a
NaCl diet. Male rats were fed a control diet or a NaCl diet and administered either placebo
or 10, 20 or 40 mg of γ-Toc. The rat urine was collected for 24 hours (divided into 6 hour
periods) and the 2,7,8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (γ-CEHC) level, the
sodium excretion content, and the urine volume were determined. The 24-hour γ-CEHC and
sodium levels in the urine of the NaCl groups given 20 mg or 40 mg γ-Toc were significantly
higher than those in the placebo group. The peak levels of urine sodium and γ-CEHC in the
NaCl group given 40 mg γ-Toc appeared at 0–6 h, which was a more rapid increase than that
seen in the group given 20 mg γ-Toc. The 24-hour urine volumes of the NaCl groups given 10
and 20 mg γ-Toc were significantly higher than the urine volume of the placebo group. Our
findings suggested that γ-Toc increased sodium excretion in a dose-dependent manner in rats
fed a NaCl diet. Moreover, a high dose of γ-Toc may accelerate its metabolism and cause an
increase in the rate of sodium excretion.
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Introduction
Dietary salt intake plays a major role in the onset and
development of hypertension [1, 2]. Observational studies
have shown a positive relationship between salt intake and
blood pressure [3]. Salt intake has been reported to be high
in the Japanese population [4] and it is thus presumed that
there is a high incidence of hypertension in this country.
Natriuretic hormone is an effective vasodilator and induces
diuretic. As a pharmacological treatment, the hormone
improves hypertension and inhibits the development of cardiac
failure [5, 6]. The γ-tocopherol (γ-Toc) urinary metabolite,
2,7,8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (γ-
CEHC), plays a role similar to natriuretic hormones [7–9]
(Fig. 1). γ-Toc and α-Toc are rich in foods such as nuts and
vegetable oils. However, α-Toc exists more abundantly in
animal plasma and tissue and is more biologically active
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than γ-Toc. This is due to the presence of α-Toc transfer
protein in the cytoplasm of hepatocytes. This protein clearly
discriminates  α-Toc from γ-Toc [10,  11]. In addition,
absorbed  γ-Toc rapidly disappears from plasma and is
metabolized to γ-CEHC.
Recently, we showed that the oral administration of 20 mg
γ-Toc could cause natriuresis and diauresis in rats given 5%
NaCl diet [12]. γ-Toc acts as a natriuretic hormone precursor
in these circumstances. However, it was unknown if γ-Toc
has natriuretic potency at a dose lower or higher than 20 mg
in rats given a NaCl diet. In this study, we investigated
whether γ-Toc could accelerate sodium excretion in a dose-
dependent manner in rats given a 5% NaCl diet.
Materials and Methods
Materials
γ-Toc and γ-CEHC were donated by Eisai Co. (Tokyo,
Japan). All agents used in this study were either HPLC grade
or reagent grade.
Experimental animals
This experiment was carried out under the guidelines of the
Animal Committee of Ochanomizu University. 7-week-old
male Sprague-Dawley rats (n = 44) were purchased from
Clea Japan Co. Ltd. (Tokyo, Japan) and kept individually in
stainless steel cages at 22 ± 1°C and 55 % humidity with a
12 h light/dark cycle.
The rats were fed a commercial diet (CE-2; Clea Japan
Co., Ltd.) for 1 week. The rats were subsequently divided
into 2 groups. The control group was fed a vitamin E-
deficient diet (AIN-76 modified by Eisai.Co.; Funabashi
Noujyou, Chiba, Japan), and the other group was fed a high-
NaCl diet (5% NaCl added to the control diet ) for the next 4
weeks. The vitamin E-defecient diet consisted of 236.8 g
sucrose, 236.8 g glucose, 189.5 g casein (vitamin free),
142.1 g cornstarch, 47.4 g filter paper, 33.2 g mineral
mixture, 9.5 g vitamin mixture except vitamin E, 2.8 g
dl-methyonine, 1.9 g choline bitartate, and 100 g stripped
corn oil. The NaCl diet consisted of the same ingredients as
the vitamin E-deficient diet with the addition of 50 g NaCl
per kilogram. Water was given ad libitum; however, food
was given in a regimen of 20 g/day for the initial week and
25 g/day for the following 3 weeks.
Study population and design
These 2 groups were subdivided into 4 groups after 12
hours of fasting. The placebo group (n = 5) was given a
0.5 ml dosage of stripped corn oil, while γ-Toc group (n =6 )
was given 0.5 ml of stripped corn oil containing 10, 20,
40 mg of γ-Toc. After the oral administration of γ-Toc or a
placebo, the rats were housed individually in metabolic
cages.
Collection of urine samples
Urine was collected in flasks at 6 h intervals for 24 h.
The urine was cooled with dry ice after collection. All urine
samples were immediately stored at −20°C until further
analyzed.
Determination of the urine volume, sodium content, and
potassium content in rat urine
The urine volume and creatinine content were measured
after each urine collection. The creatinine in each urine
sample was measured by the Jaffe method [13, 14] (Hitachi
auto analyzer 7011, Hitachi Medical Co., Tokyo, Japan).
The sodium and potassium contents in the urine were
determined by an electrode method [15, 16] (Hitachi auto
analyzer 7011, Hitachi Medical Co., Tokyo, Japan).
Extraction of γ-CEHC from the rat urine and the chromato-
graphic apparatus and conditions
γ-CEHC content in the urine was analyzed by the method
reported by Kiyose et al. [15]. γ-CEHC in the urine was
treated with 3 N methanolic HCl to hydrolyze conjugates
and to promote esterification. γ-CEHC-methyl ester in the
urine was determined by HPLC-ECD. The HPLC system
consisted of the Shiseido intelligent HPLC pump (SI-2)
Fig. 1.  γ-Tocopherol (γ-Toc) is metabolized to 2,7,8-trimethyl-2-
(2'-carboxyethyl)-6-hydroxychroman (γ-CEHC), which
is a natriuretic hormone.γ-Tocopherol Accelerated Sodium Excretion with a High Sodium Intake
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(Shiseido Co., Kyoto, Japan), JASCO intelligent sampler
(AS-950-10), a column oven (860-10), and an integrator
(807-IT) (JASCO Co., Tokyo, Japan) while applying a
potential of +0.6 V vs Ag/AgCl. The γ-CEHC analysis was
performed at 35°C using an RP-18T C18 column
(250 × 2.0 mm I.D., IRICA Instruments Inc., Tokyo, Japan).
The mobile phase was performed using acetonitrile-water
(40/60, v/v) with 50 mM sodium perchlorate at a flow rate of
0.2 ml/min.
Statistical analysis
Statistical analyses were performed using the Stat View
Version 5.0 software package (SAS Institute Inc., NC.). All
results were expressed as the mean ± SEM. The significance
between the 8 experimental groups was evaluated using the
multivariate ANOVA (MANOVA).
Results
γ-CEHC Excretion into Rat Urine
The γ-CEHC excretion over the course of 24 h is shown
in Fig. 2. The urine levels of γ-CEHC in the NaCl groups
given 10 mg γ-Toc (283 ± 60 µg/24 h urine; p<0.01), 20 mg
γ-Toc (315 ± 45 µg/24 h urine; p<0.01) and 40 mg γ-Toc
(333 ± 23 µg/24 h urine; p<0.01) were significantly higher
than the γ-CEHC levels in the control groups (10 mg;
89 ± 22 µg/24 h urine, 20 mg; 120 ± 30 µg/24 h urine, and
40 mg; 156 ± 38 µg/24 h urine). Furthermore, the peak
levels of γ-CEHC in the NaCl groups given 10 mg (6–12 h;
p<0.05, 12–18 h; p<0.05), 20 mg (6–12 h; p<0.05) and
40 mg γ-Toc (0–6 h; p<0.01) were significantly higher than
the peak levels of the control group at each time period
(Fig. 2). The peak level at 6–12 h in the NaCl group given
20 mg γ-Toc was similar to the results from our previous
study [12]. The oral administration of γ-Toc has a positive
relationship with γ-CEHC urine levels in a dose-dependent
manner in rats fed control diet (r2 = 0.4139, p<0.001) and
5% NaCl diet (r2 = 0.1764, p<0.05) (Fig. 3A).
Urine volume
Fig. 4 shows the changes in the urine volume level
throughout the 24 h period after the oral administration of
the placebo or γ-Toc. There were no significant differences
in the urine volume level between the control group given
the placebo and the control group given γ-Toc. However, the
24-h urine volumes levels in the NaCl group given 10 mg
(35.1 ± 9.3 ml;  p<0.05) or 20 mg γ-Toc (51.4 ± 12.6 ml;
p<0.05) were significantly higher than the urine volume
level of the NaCl group given the placebo (12.5 ± 1.9 ml).
Furthermore, the peak urine volumes levels in the NaCl
group given 10 mg γ-Toc (12–18 h; p<0.05) and 20 mg (12–
18 h; p<0.05) were significantly higher at each time period
than those in the NaCl group given a placebo. The peak level
Fig. 2.  Changes in 2,7,8-trimethyl-2-(2'-carboxyethyl)-6-
hydroxychroman (γ-CEHC) levels in rat urine after the
oral administration of placebo or γ-tocopherol (γ-Toc).
The rats were fed a vitamin E-deficient diet (control) or a
NaCl diet for 4 weeks. In each group, one subgroup was
administered a placebo, while the others were given
10 mg (γ10), 20 mg (γ20), 40 mg (γ40) of γ-Toc. After
the oral administration of single dose of the placebo or γ-
Toc, the rat urine was collected for 24 h (divided into 6 h
periods) and then the γ-CEHC content was measured.
The values are the mean ± SEM. of 4–6 rats, *p<0.05,
**p<0.01 vs the control diet group at each time period.H. Uto-Kondo et al.
J. Clin. Biochem. Nutr.
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in the NaCl group given 20 mg γ-Toc between 12–18 h was
similar to the results from our previous study [12]. Ac-
cording to these findings, the NaCl groups given only 10 mg
or 20 mg γ-Toc had higher urine volumes than the rats in the
NaCl groups given 40 mg γ-Toc or the placebo. On the other
hand, no substantial changes were observed in the creatinin
content in the rat urine in all experimental groups (data not
shown).
Sodium and potassium excretion into rat urine
We examined the effects of γ-Toc administration on
sodium excretion and potassium excretion in rat urine. γ-Toc
accelerates sodium excretion in a dose-dependent manner in
rats with a high sodium intake. The 24-hour sodium levels in
the urine of rats given 20 mg γ-Toc (1.2 ± 0.4 mEq; p<0.05)
and 40 mg γ-Toc (4.5 ± 0.7 mEq; p<0.01) were significantly
higher than that the sodium levels in the NaCl group given a
Fig. 3.  Correlation between the level of urine sodium and 2,7,8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (γ-CEHC) and γ-Toc.
The rats were fed a control diet (closed circle) or NaCl diet (closed triangle) for 4 weeks. One subgroup was administered a
placebo, while the others were given 10, 20, 40 mg of γ-Toc. A. Correlation between the urine sodium level and the level of
2,7,8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (γ-CEHC) throughout the 24 h period. These plots display a linear
relationship at r2 = 0.4139, p<0.001 (closed circle) and r2 = 0.4199, p<0.001 (closed triangle). B. Correlation between the urine
sodium level and the dose of γ-tocopherol (γ-Toc) throughout the 24 hour period. These plots display a linear relationship at
r2 = 0.0536 (closed circle) and r2 = 0.1601 (closed triangle). C. Correlation between the level of 2,7,8-trimethyl-2-(2'-
carboxyethyl)-6-hydroxychroman (γ-CEHC) and the dose of γ-tocopherol (γ-Toc) throughout the 24 h period. These plots
display a linear relationship at r2 = 0.2115, p<0.05 (closed circle) and r2 = 0.4528, p<0.001 (closed triangle).γ-Tocopherol Accelerated Sodium Excretion with a High Sodium Intake
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placebo (Fig. 5). Furthermore, the peak sodium levels in the
NaCl groups given 20 mg γ-Toc (12–18 h; p<0.05) and
40 mg  γ-Toc (0–6 h; p<0.01, 6–12 h; p<0.05, 12–18 h;
p<0.05) were significantly higher than the levels in the NaCl
group given a placebo at each time period (Fig. 5). The peak
level in the NaCl group given 20 mg γ-Toc between 12–18 h
was the same as the result in our previous report [12]. A
positive correlation was seen between sodium excretion and
Fig. 4.  Changes in the rat urine volume level after the oral
administration of placebo and γ-tocopherol (γ-Toc). The
rats were fed a vitamin E-deficient diet (control) or a
NaCl diet for 4 weeks. In each group, one subgroup was
a placebo, while the others were given 10 mg (γ10),
20 mg (γ20), 40 mg (γ40) of γ-Toc. After the oral
administration of single dose of the placebo or γ-Toc, the
rat urine was collected for 24 h (divided into 6 h periods)
and the urine volume was determined. The values are the
mean ± SEM of 4–6 rats, *p<0.05 vs placebo at each
time period.
Fig. 5.  Changes in the urine sodium levels after the oral
administration of a placebo or γ-tocopherol (γ-Toc). The
rats were fed a vitamin E-deficient diet (control) or a
NaCl diet for 4 weeks. In each group, one subgroup was
administered a placebo, while the others were given
10 mg (γ10), 20 mg (γ20), 40 mg (γ40) of γ-Toc. After
the oral administration of single dose of the placebo or γ-
Toc, the rat urine was collected for 24 h (divided into
6 h periods) and the sodium content was measured. The
values are the mean ± SEM of 4–6 rats, *p<0.05,
**p<0.01 vs placebo at each time period.H. Uto-Kondo et al.
J. Clin. Biochem. Nutr.
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γ-CEHC excretion in rat urine of the NaCl group (r2 =
0.1061, p<0.05). On the other hand, no substantial changes
were observed them in rat urine of the control group
(r2 = 0.0536) (Fig. 3B). Furthermore, γ-Toc administration
has a positive relationship with sodium excretion in a dose-
dependent manner in rats fed a control diet (r2 =0 . 2 1 1 5 ,
p<0.05) and 5% NaCl diet (r2 = 0.4528, p<0.001) (Fig. 3C).
In contrast, no substantial changes were observed in the
potassium excretion rates in the rat urine in all experimental
groups (Fig. 6).
According to these findings, γ-Toc accelerates sodium
excretion in a dose-dependent manner in rats with a high
sodium intake, however, γ-Toc has no effect on potassium
excretion.
Discussion
γ-CEHC, a γ-Toc metabolite, has exhibited important
pharmacological activities as a natriuretic factor in recent
studies [7–9]. We previously showed that γ-Toc had a
natriuretic potency after the oral administration of 20 mg
γ-Toc in rats fed a 5% NaCl diet [12]. In this study, we
investigated whether γ-Toc accelerated sodium excretion in
a dose-dependent manner (γ-Toc 10 mg, 20 mg and 40 mg)
in rats fed a 5% NaCl diet.
The 24-h urine sodium contents in the groups given 20 mg
and 40 mg γ-Toc were significantly higher than those in the
group given a placebo (Fig. 5). The urine sodium content
increased in a dose-dependent manner in groups given
20 mg and 40 mg γ-Toc. The 24-h urine γ-CEHC contents in
the groups given 10 mg, 20 mg, and 40 mg γ-Toc were also
significantly higher than those in the control group (Fig. 2).
Furthermore,  γ-Toc administration has a positive
relationship with γ-CEHC and the sodium excretion in a
dose-dependent manner in all groups (Fig. 3A, 3C). On the
other hand, there was a positive relationship between sodium
excretion and γ-CEHC excretion only in the NaCl group
(Fig. 3B).These results indicate that the rate of sodium
excretion will increase as the dose of γ-CEHC increases only
with a high sodium intake.
The levels of sodium excretion and γ-CEHC in the NaCl
group given 40 mg γ-Toc were significantly higher than the
NaCl group given a placebo during the 0 to 6 hour period
(Figs. 2, 5). In the NaCl group given 40 mg γ-Toc, the peak
levels of urine sodium and γ-CEHC excretion appeared at 12
hours, which was faster rate than that in the group given
20 mg γ-Toc (Figs. 2, 5). The time lag in peak levels was
investigated in our previous studies comparing γ-Toc and
γ-tocotrienol [12, 16]. We compared the rate of sodium and
γ-CEHC excretion between NaCl groups given γ-Toc and
γ-tocotrienol. The peak sodium content level of the groups
given  γ-tocotrienol (0–12 h) appeared 6 hours before the
peak sodium content level in the group given γ-Toc (6–12 h).
Regarding these time lags, we presumed that a higher dose
of  γ-Toc enhanced its metabolism as well as the rate of
sodium excretion in rats with a high sodium intake. We
presumed that the metabolism of γ-Toc accelerates with a
high sodium intake.
Fig. 6.  Changes in the urine potassium content after the oral
administration of placebo or γ-tocopherol (γ-Toc). The
rats were fed a vitamin E-deficient diet (control) or a
NaCl diet for 4 weeks. In each group, one subgroup was
administered a placebo, while the others were given
10 mg (γ10), 20 mg (γ20), 40 mg (γ40) of γ-Toc. After
the oral administration of single dose of the placebo or γ-
Toc, the rat urine was collected for 24 h (divided into
6 h periods) and the potassium content was measured.
The values are the mean ± SEM of 4–6 rats.γ-Tocopherol Accelerated Sodium Excretion with a High Sodium Intake
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We therefore conclude that γ-Toc stimulates the urinary
output only in the presence of a high sodium intake. It is
assumed that there may be a relationship between sodium
excretion and the production of γ-CEHC.
The urine volume in the NaCl group given 40 mg γ-Toc
was similar to urine volume in the NaCl group given placebo
(Fig. 4). The reason for this similarity was not clear because
we did not measure the quantity of water consumed by
the rats, but we presumed that rats in the NaCl group given
γ-Toc 40 mg drank a small quantity of water. There was
no significant differences in the urine potassium content in
any of the experimental groups (Fig. 6). This result was
consistent with our previous reports [12, 16]. The similar
levels of potassium excretion are due to the fact that γ-
CEHC inhibits the 70pS ATP-sensitive K+ (KATP) channel in
the thick ascending limb of the loop of Henle [7–9].
Antihypertensive drugs usually excrete potassium along
with sodium, which results in hypokalemia [17, 18]. However,
γ-Toc might effectively increase the rate of sodium excretion
while maintaining the serum potassium level. In conclusion,
a high dose of γ-Toc accelerated the rate of sodium excretion
and its metabolism; however, such a dose of γ-Toc might not
increase the urine volume in rats fed a NaCl diet.
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